The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect?
Abstract
In view of the fact that insulin resistance is associated with atherogenesis and that troglitazone, an insulin sensitizer, has anti-inflammatory effects, which may be potentially antiatherogenic in the long term, we have now investigated whether insulin has potential anti-inflammatory effects. We infused 2.0 to 2.5 IU/h in 5% dextrose (100 mL/h) iv into 10 obese subjects for 4 h followed by 5% dextrose alone for 2 h. The rate of insulin infusion was varied to maintain glucose concentrations as close to the baseline as possible. Blood samples were obtained before and at 2, 4, and 6 h. Subjects were also infused with 5% dextrose without insulin and with saline on separate occasions. Intranuclear nuclear factor κB (NFκB) in mononuclear cells fell at 2 and further at 4 h, reverting toward the baseline at 6 h (P < 0.05). IκB increased significantly at 2 h, increasing further at 4 h and remaining elevated at 6 h (P < 0.001). Reactive oxygen species (ROS) generation by mononuclear cells fell significantly at 2 h and fell further at 4 h; it partially reverted to baseline at 6 h (P < 0.005). p47phox subunit, the key protein of nicotinamide adenine dinucleotide phosphate oxidase also fell at 2 h and 4 h, reverting toward the baseline at 6 h (P < 0.05). In addition, soluble intercellular adhesion molecule-1 (sICAM-1), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor-1 (PAI-1) fell significantly following insulin infusion. Glucose or saline infusions without insulin caused no alteration in NFκB, IκB, ROS generation, p47phox subunit, sICAM-1, MCP-1, or PAI-1. We conclude that insulin has a potent acute anti-inflammatory effect including a reduction in intranuclear NFκB, an increase in IκB, and decreases in ROS generation, p47phox subunit, plasma soluble intercellular adhesion molecule-1 (sICAM-1), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor-1 (PAI-1. This acute anti-inflammatory effect, if demonstrated in the long term, may have implications for atherosclerosis and its complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
Grilli, M., Chiu, J. J.-S., & Lenardo, M. J. (1993) · International Review of Cytology · doi:10.1016/s0074-7696(08)61873-2 · Cited by 936
Malmberg, K., Norhammar, A., Wedel, H., & Rydén, L. (1999) · Circulation · doi:10.1161/01.cir.99.20.2626 · Cited by 847
Oxidative damage to DNA in diabetes mellitus
Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D., & Nicotera, T. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90013-6 · Cited by 787
Self-citationZeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726 · cited 1×
“Insulin is known to be a vasodilator (32, 33) and exerts this effect through nitric oxide release ( 34 ) and the induction of endothelial nitric oxide synthase (35).”
Background
Research works printed but not linked: 6
- Panasenko, 1991, Free-radical generation by monocytes and neutrophils: a possible cause of plasma lipoprotein modification., Biomed Sci, 2, 581
- 1991, Biochemistry of the arterial wall in developing atherosclerosis., Ann N Y Acad Sci, 623, 40, 10.1111/j.1749-6632.1991.tb43717.x · doi:10.1111/j.1749-6632.1991.tb43717.x
- 1996, 30, 1
- 1997, Cardiovascular disease in diabetes and operative risk., Rays, 22, 595
- Dandona, 1998, Effect of hydrocortisone on oxygen free radical generation by mononuclear cells., Metabolism, 47, 788, 10.1016/S0026-0495(98)90113-5 · doi:10.1016/s0026-0495(98)90113-5
- Grunberger, 1990, Diacylglycerols modulate phosphorylation of the insulin receptor from human mononuclear cells., Eur J Biochem, 187, 191, 10.1111/j.1432-1033.1990.tb15294.x · doi:10.1111/j.1432-1033.1990.tb15294.x
Cited by
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Self-citationVan den Berghe, G., Wouters, P. J., Bouillon, R., Weekers, F., Verwaest, C., Schetz, M., Vlasselaers, D., Ferdinande, P., & Lauwers, P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045568.12881.10 · Cited by 1,455
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., & Garg, R. (2005) · Circulation · doi:10.1161/01.cir.0000158483.13093.9d · Cited by 1,263
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Russell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,048
Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms
Mora, S., Cook, N., Buring, J. E., Ridker, P. M., & Lee, I.-M. (2007) · Circulation · doi:10.1161/circulationaha.107.729939 · Cited by 1,000
Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
NADPH Oxidases, Reactive Oxygen Species, and Hypertension
Paravicini, T. M., & Touyz, R. M. (2008) · Diabetes Care · doi:10.2337/dc08-s247 · Cited by 724
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Steinberger, J., Daniels, S. R., Eckel, R. H., Hayman, L., Lustig, R. H., McCrindle, B., & Mietus-Snyder, M. L. (2009) · Circulation · doi:10.1161/circulationaha.108.191394 · Cited by 712
Tripathy, D., Mohanty, P., Dhindsa, S., Syed, T., Ghanim, H., Aljada, A., & Dandona, P. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2882 · Cited by 660
Self-citationCirculating Mononuclear Cells in the Obese Are in a Proinflammatory State
Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T., Mohanty, P., & Dandona, P. (2004) · Circulation · doi:10.1161/01.cir.0000142055.53122.fa · Cited by 611
Self-citationTelomere length assessment: Biomarker of chronic oxidative stress?
Houben, J. M. J., Moonen, H. J. J., van Schooten, F. J., & Hageman, G. J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.001 · Cited by 558
How does blood glucose control with insulin save lives in intensive care?
Van den Berghe, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423506 · Cited by 550
Hansen, T. K., Thiel, S., Wouters, P. J., Christiansen, J. S., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021478 · Cited by 499
Stentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2079 · Cited by 497
Ghanim, H., Abuaysheh, S., Sia, C. L., Korzeniewski, K., Chaudhuri, A., Fernandez-Real, J. M., & Dandona, P. (2009) · Diabetes Care · doi:10.2337/dc09-0979 · Cited by 494
Self-citationAcute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects
Turina, M., Fry, D. E., & Polk, H. C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000170106.61978.d8 · Cited by 490
Exercise as an anti-inflammatory therapy for rheumatic diseases—Myokine regulation
Benatti, F. B., & Pedersen, B. K. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.193 · Cited by 474
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Aggarwal, B. B. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104755 · Cited by 471
Intensive insulin therapy protects the endothelium of critically ill patients
Langouche, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25385 · Cited by 467
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1696 · Cited by 458
Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis
Gustafson, B., Hammarstedt, A., Andersson, C. X., & Smith, U. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147835 · Cited by 436
Adipose tissue macrophages: going off track during obesity
Boutens, L., & Stienstra, R. (2016) · Diabetologia · doi:10.1007/s00125-016-3904-9 · Cited by 428
Stress-hyperglycemia, insulin and immunomodulation in sepsis
Marik, P. E., & Raghavan, M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2167-y · Cited by 419
Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
Urakawa, H., Katsuki, A., Sumida, Y., Gabazza, E. C., Murashima, S., Morioka, K., Maruyama, N., Kitagawa, N., Tanaka, T., Hori, Y., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030202 · Cited by 416
An immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394
Postoperative hyperglycemia and surgical site infection in general surgery patients
Ata, A. (2010) · Archives of Surgery · doi:10.1001/archsurg.2010.179 · Cited by 379
Evidence for a Potent Antiinflammatory Effect of Rosiglitazone
Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Al-Haddad, W., Dhindsa, S., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032103 · Cited by 379
Self-citationBalagopal, P. (., de Ferranti, S. D., Cook, S., Daniels, S. R., Gidding, S. S., Hayman, L. L., McCrindle, B. W., Mietus-Snyder, M. L., & Steinberger, J. (2011) · Circulation · doi:10.1161/cir.0b013e31821c7c64 · Cited by 352
The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study
Cheung, N. W., Wong, V. W., & McLean, M. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1894 · Cited by 335
Macrophage functions in lean and obese adipose tissue
Thomas, D., & Apovian, C. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.005 · Cited by 316
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.039 · Cited by 309
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
Goldfine, A. B., Silver, R., Aldhahi, W., Cai, D., Tatro, E., Lee, J., & Shoelson, S. E. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00026.x · Cited by 294
Exenatide Exerts a Potent Antiinflammatory Effect
Chaudhuri, A., Ghanim, H., Vora, M., Sia, C. L., Korzeniewski, K., Dhindsa, S., Makdissi, A., & Dandona, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1508 · Cited by 284
Self-citationTargeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Sandhu, S., Green, K., Makdissi, A., Hejna, J., Chaudhuri, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1518 · Cited by 286
Self-citationChaudhuri, A., Janicke, D., Wilson, M. F., Tripathy, D., Garg, R., Bandyopadhyay, A., Calieri, J., Hoffmeyer, D., Syed, T., Ghanim, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000116762.77804.fc · Cited by 277
Self-citationInsulin signalling mechanisms for triacylglycerol storage
Czech, M. P., Tencerova, M., Pedersen, D. J., & Aouadi, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2869-1 · Cited by 276
Omentin: A Novel Link Between Inflammation, Diabesity, and Cardiovascular Disease
Tan, B. K., Adya, R., & Randeva, H. S. (2010) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.12.002 · Cited by 255
The Metabolic Syndrome and Inflammation
Sutherland, J. P., McKinley, B., & Eckel, R. H. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.82 · Cited by 243
Dickinson, S., Hancock, D. P., Petocz, P., Ceriello, A., & Brand-Miller, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1188 · Cited by 184
Insulin says NO to cardiovascular disease
Yu, Q., Gao, F., & Ma, X. L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq349 · Cited by 172
Nesto, R. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01296.x · Cited by 140
Pagnin, E., Fadini, G., de Toni, R., Tiengo, A., Calò, L., & Avogaro, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1283 · Cited by 127
Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome
Fortuño, A., San José, G., Moreno, M. U., Beloqui, O., Díez, J., & Zalba, G. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0751 · Cited by 128
Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms
Kankaanranta, H., Kauppi, P., Tuomisto, L. E., & Ilmarinen, P. (2016) · Mediators of Inflammation · doi:10.1155/2016/3690628 · Cited by 122
“Insulin reduced short-term activation of NF-κB and expression of many inflammatory mediators (IL-4, ADAM33, LIGHT, and LTBR) related to asthma in these cells [183, 184].”
BackgroundFatty acids and the metabolic syndrome
Roche, H. M. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004405 · Cited by 113
“A low-dose infusion of insulin reduces mononuclear cell reactive oxygen species generation, suppresses NF-kB DNA binding, induces inhibitor of kBa expression and suppresses concentrations of plasma intercellular adhesion cellular molecule-1, plasminogen-activator inhibitor-1 and monocyte chemotactic protein-1 (Dandona…”
BackgroundBiobaku, F., Ghanim, H., Batra, M., & Dandona, P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01833 · Cited by 104
Self-citationInsulin: An endogenous cardioprotector
Das, U. N. (2003) · Current Opinion in Critical Care · doi:10.1097/00075198-200310000-00007 · Cited by 97
Ghanim, H., Aljada, A., Daoud, N., Deopurkar, R., Chaudhuri, A., & Dandona, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0508-9 · Cited by 96
Tobore, T. O. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112560 · Cited by 73
González, F., Nair, K. S., Daniels, J. K., Basal, E., & Schimke, J. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2011 · Cited by 70
Chan, J. L., Bullen, J., Stoyneva, V., DePaoli, A. M., Addy, C., & Mantzoros, C. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1921 · Cited by 60
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00987 · Cited by 60
Ghanim, H., Batra, M., Abuaysheh, S., Green, K., Makdissi, A., Kuhadiya, N. D., Chaudhuri, A., & Dandona, P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2669 · Cited by 46
Self-citationCardiovascular Risk Factors Associated with Insulin Resistance: Effects of Oral Antidiabetic Agents
Granberry, M. C., & Fonseca, V. A. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505030-00006 · Cited by 38
González, F., Sia, C. L., Shepard, M. K., Rote, N. S., & Minium, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2046 · Cited by 35
Lejawa, M., Osadnik, K., Osadnik, T., & Pawlas, N. (2021) · Antioxidants · doi:10.3390/antiox10010093 · Cited by 30
“Previous studies demonstrated that in obese individuals, insulin resistance may cause inflammation, which is one of the main causes of MetS and type 2 diabetes [47,48].”
BackgroundLiu, J., Ge, Y., Wu, S., Ma, D., Xu, W., Zhang, Y., & Yang, Y. (2019) · Aging · doi:10.18632/aging.101781 · Cited by 27
Influence of the DASH diet and other low-fat, high-carbohydrate diets on blood pressure
Delichatsios, H. K., & Welty, F. K. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0061-x · Cited by 15
Metadata
- Authors
- Dandona, P., Aljada, A., Mohanty, P., Ghanim, H., Hamouda, W., Assian, E., & Ahmad, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-07-01
- Volume
- 86
- Issue
- 7
- Pages
- 3257-3265
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2049501468
- Cited by
- 667
- References
- 39
- FWCI
- 21.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.